Brief: Orexo Announces Positive Topline Data From Clinical Study Of OX640 In Subjects With And Without Allergic Rhinitis

Orexo AB

10/01/2025 13:57

Jan 10 (Reuters) - Orexo AB  ORX.ST :
    * OREXO ANNOUNCES POSITIVE TOPLINE DATA FROM CLINICAL STUDY
OF
OX640 IN SUBJECTS WITH AND WITHOUT ALLERGIC RHINITIS
    * OREXO AB - OX640 ACHIEVED CLINICALLY RELEVANT PLASMA
LEVELS OF
EPINEPHRINE RAPIDLY
    * OREXO AB: OX640 SYSTEMIC SAFETY IN LINE WITH KNOWN
PHARMACOLOGY
OF EPINEPHRINE & LOCAL EFFECTS WERE TRANSIENT AND TOLERATED

Source text:  urn:newsml:reuters.com:*:nPn8w74Qfa
Further company coverage:  ORX.ST 

 ((Reuters.Briefs@thomsonreuters.com;))